Navigation Links
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
Date:2/3/2009

VENLO, Netherlands, Feb. 3 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN) today announced the Webcast of its fourth quarter and year-end 2008 financial results call. The Webcast will take place at 9:30 a.m. EST on Tuesday, February 10, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer.

    What:     Webcast of QIAGEN's fourth quarter and year-end 2008 financial
              results call

    When:     9:30 a.m. EST on February 10

    Where:    The Webcast is accessible at www.qiagen.com/goto/ConferenceCall

    How:      Log on to the Web at the address above

              The corresponding presentation slides are available for download
              in the investor relations section of QIAGEN's Web site at
              www.qiagen.com/goto/ConferenceCall.

    Contact:  Andreas Marathovouniotis, Russo Partners, (212) 845-4235

QIAGEN N.V., a Netherlands holding company, is the leading provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 consumable products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include what is considered to be the broadest panel of molecular diagnostic tests available worldwide. This panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer.

QIAGEN employs more than 3,000 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com.

(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/products/player/index.html, or The Windows Media Player, downloadable free from www.microsoft.com and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to webmaster@vdat.com.)


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
2. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
3. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call
6. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
7. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
8. Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
10. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
11. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased to ... Popper and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. , ... the United States, linking US and Asia Pacific healthcare innovators with capital and investors. ...
(Date:5/15/2020)... CAMBRIDGE, Mass. (PRWEB) , ... May 14, 2020 ... ... alternative but to undergo multiple open heart surgeries before becoming adults. ... child. , To address this critical unmet need, the Department of Defense ...
(Date:5/14/2020)... ... May 12, 2020 , ... DuPont Nutrition ... distribution partner for all personal care ingredients in Russia and Belarus. Beginning May ... preservative portfolio for personal care. , The GENENCARE®OSMS product line contains ...
(Date:5/14/2020)... ... May 13, 2020 , ... ... or phenotypic readouts, providing little or no information on the drug’s mechanism of ... comprehensive characterization of compounds by measuring the activity of molecular pathways. This information ...
Breaking Biology Technology:
(Date:5/1/2020)... ... ... More than 600 people undergo genetic counseling and testing each year as ... two genetic counselors. , My Gene Counsel , a digital health company that ... Rick Program to ensure that UConn’s patients who have undergone genetic testing for cancer ...
(Date:4/30/2020)... ... 2020 , ... At the start of 2020 ILC ... a wide range of industries including pharmaceutical and biopharmaceutical manufacturing, healthcare, food and ... decade, it was clear to company leadership that they would have to adapt ...
(Date:4/26/2020)... , ... April 23, 2020 , ... A team of ... is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). ... would be another potential treatment option for COVID-19. , The efforts are being led ...
Breaking Biology News(10 mins):